Toward Better Predictions of Chemosensitivity: Comparative Study of Conventional and Simulated Chemosensitivity Tests for Bladder Cancer Cell Lines.
作者信息
Kim Taek Sang, Chung Jae Il, Noh Geun Hwa, Hwang Hyunyong
机构信息
Department of Urology, Kosin University Gospel Hospital, Busan, Korea.
Department of Urology, Inje University, Busan Paik Hospital, Busan, Korea.
出版信息
Ann Lab Med. 2017 Jul;37(4):343-345. doi: 10.3343/alm.2017.37.4.343.
Abstract
摘要
相似文献
1
Toward Better Predictions of Chemosensitivity: Comparative Study of Conventional and Simulated Chemosensitivity Tests for Bladder Cancer Cell Lines.迈向更好的化学敏感性预测：膀胱癌细胞系传统与模拟化学敏感性测试的比较研究
Ann Lab Med. 2017 Jul;37(4):343-345. doi: 10.3343/alm.2017.37.4.343.
2
The effect of photochemical internalization of bleomycin in the treatment of urothelial carcinoma of the bladder: an in vitro study.博来霉素光化学内化作用在膀胱尿路上皮癌治疗中的效果：一项体外研究
Urol Oncol. 2014 Jan;32(1):49.e1-6. doi: 10.1016/j.urolonc.2013.07.005. Epub 2013 Oct 17.
3
Temsirolimus improves cytotoxic efficacy of cisplatin and gemcitabine against urinary bladder cancer cell lines.坦西莫司可提高顺铂和吉西他滨对膀胱癌细胞系的细胞毒性疗效。
Urol Oncol. 2014 Jan;32(1):41.e11-22. doi: 10.1016/j.urolonc.2013.04.012. Epub 2013 Sep 10.
4
Chondroitin sulphate enhances the antitumor activity of gemcitabine and mitomycin-C in bladder cancer cells with different mechanisms.硫酸软骨素通过不同机制增强吉西他滨和丝裂霉素 C 对膀胱癌细胞的抗肿瘤活性。
Oncol Rep. 2012 Feb;27(2):409-15. doi: 10.3892/or.2011.1526. Epub 2011 Oct 31.
5
Effect of hyperthermia on the cytotoxicity of 4 chemotherapeutic agents currently used for the treatment of transitional cell carcinoma of the bladder: an in vitro study.热疗对目前用于治疗膀胱移行细胞癌的4种化疗药物细胞毒性的影响：一项体外研究。
J Urol. 2005 Apr;173(4):1375-80. doi: 10.1097/01.ju.0000146274.85012.e1.
6
Olive Mill Wastewater Inhibits Growth and Proliferation of Cisplatin- and Gemcitabine-Resistant Bladder Cancer Cells In Vitro by Down-Regulating the Akt/mTOR-Signaling Pathway.橄榄油厂废水通过下调 Akt/mTOR 信号通路抑制顺铂和吉西他滨耐药膀胱癌细胞的体外生长和增殖。
Nutrients. 2022 Jan 15;14(2):369. doi: 10.3390/nu14020369.
7
Long non-coding RNA UCA1 promotes cisplatin/gemcitabine resistance through CREB modulating miR-196a-5p in bladder cancer cells.长链非编码 RNA UCA1 通过调控 CREB 介导的 miR-196a-5p 促进膀胱癌顺铂/吉西他滨耐药。
Cancer Lett. 2016 Nov 1;382(1):64-76. doi: 10.1016/j.canlet.2016.08.015. Epub 2016 Aug 31.
8
Cytotoxic activity of anticancer drugs on hepatocellular carcinoma cells in hypoxic-hyponutritional culture.抗癌药物在低氧-低营养培养条件下对肝癌细胞的细胞毒性活性。
Int Surg. 2014 Nov-Dec;99(6):745-52. doi: 10.9738/INTSURG-D-14-00073.1.
9
Everolimus enhances gemcitabine-induced cytotoxicity in bladder-cancer cell lines.依维莫司增强吉西他滨在膀胱癌细胞系中的细胞毒性。
J Toxicol Environ Health A. 2012;75(13-15):788-99. doi: 10.1080/15287394.2012.690325.
10
Synergistic induction of apoptosis by mapatumumab and anthracyclines in human bladder cancer cells.Mapatumumab与蒽环类药物协同诱导人膀胱癌细胞凋亡
Oncol Rep. 2015 Feb;33(2):566-72. doi: 10.3892/or.2014.3654. Epub 2014 Dec 5.
引用本文的文献
1
Increased miR-323a induces bladder cancer cell apoptosis by suppressing c-Met.miR-323a 的增加通过抑制 c-Met 诱导膀胱癌细胞凋亡。
Kaohsiung J Med Sci. 2019 Sep;35(9):542-549. doi: 10.1002/kjm2.12091. Epub 2019 Jun 10.
本文引用的文献
1
Oncological outcomes of a single but extensive transurethral resection followed by appropriate intra-vesical instillation therapy for newly diagnosed non-muscle-invasive bladder cancer.对于新诊断的非肌层浸润性膀胱癌，单次广泛经尿道切除术后联合适当的膀胱内灌注治疗的肿瘤学结局。
Int Urol Nephrol. 2015 Sep;47(9):1509-14. doi: 10.1007/s11255-015-1048-3. Epub 2015 Jul 7.
2
BCG+MMC trial: adding mitomycin C to BCG as adjuvant intravesical therapy for high-risk, non-muscle-invasive bladder cancer: a randomised phase III trial (ANZUP 1301).卡介苗联合丝裂霉素试验：在卡介苗基础上加用丝裂霉素作为高危非肌层浸润性膀胱癌的辅助膀胱内灌注治疗：一项随机III期试验（ANZUP 1301）
BMC Cancer. 2015 May 27;15:432. doi: 10.1186/s12885-015-1431-6.
3
Prospective randomized trial of hexylaminolevulinate photodynamic-assisted transurethral resection of bladder tumour (TURBT) plus single-shot intravesical mitomycin C vs conventional white-light TURBT plus mitomycin C in newly presenting non-muscle-invasive bladder cancer.前瞻性随机临床试验：六氨基己酸光动力辅助经尿道膀胱肿瘤切除术（TURBT）联合单次膀胱内丝裂霉素 C 治疗与传统白光 TURBT 联合丝裂霉素 C 治疗新诊断的非肌层浸润性膀胱癌。
BJU Int. 2013 Dec;112(8):1096-104. doi: 10.1111/bju.12355.
4
Current intravesical therapy for non-muscle invasive bladder cancer.目前用于非肌肉浸润性膀胱癌的膀胱内治疗。
Expert Opin Biol Ther. 2013 Oct;13(10):1371-85. doi: 10.1517/14712598.2013.824421. Epub 2013 Aug 20.
5
European guidelines on upper tract urothelial carcinomas: 2013 update.欧洲上尿路尿路上皮癌指南：2013 年更新版。
Eur Urol. 2013 Jun;63(6):1059-71. doi: 10.1016/j.eururo.2013.03.032. Epub 2013 Mar 19.
6
American Society of Clinical Oncology clinical practice guideline update on the use of chemotherapy sensitivity and resistance assays.美国临床肿瘤学会临床实践指南更新：化疗敏感性和耐药性检测的应用。
J Clin Oncol. 2011 Aug 20;29(24):3328-30. doi: 10.1200/JCO.2011.36.0354. Epub 2011 Jul 25.
7
A single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with stage Ta T1 bladder cancer: a meta-analysis of published results of randomized clinical trials.术后单次即刻灌注化疗可降低Ta T1期膀胱癌患者的复发风险：一项对已发表的随机临床试验结果的荟萃分析。
J Urol. 2004 Jun;171(6 Pt 1):2186-90, quiz 2435. doi: 10.1097/01.ju.0000125486.92260.b2.
Zotero 插件